Copyright
©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 97458
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.97458
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.97458
Figure 1 Common pathways and risk factors leading to endothelial dysfunction and major cardiovascular adverse events among post-kidney transplant recipients.
AGEs: Advanced glycation end products; CKD: Chronic kidney disease; CVD: Cardiovascular diseases; FFA: Free fatty acids; FGF: Fibroblast growth factor; LVH: Left ventricular hypertrophy; NO: Nitric oxide; NODAT: New-onset diabetes after transplant; PTH: Parathyroid hormone; SES: Socioeconomic status.
- Citation: Prabhahar A, Batta A, Hatwal J, Kumar V, Ramachandran R, Batta A. Endothelial dysfunction in the kidney transplant population: Current evidence and management strategies. World J Transplant 2025; 15(1): 97458
- URL: https://www.wjgnet.com/2220-3230/full/v15/i1/97458.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i1.97458